Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non–small cell lung carcinoma: long-term results and associations with pathologic response

This publication has 17 references indexed in Scilit:

• Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.
  Journal of Clinical Oncology, 1998
• Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
  Journal of Clinical Oncology, 1997
• 242 Promising long term outcome of weekly paclitaxel and carboplatin with simultaneous thoracic radiotherapy (TRT) for locally advanced non-small cell lung cancer (NSCLC)
  Lung Cancer, 1997
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
  Journal of Clinical Oncology, 1995
• The Evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Surgery for stage IIIa-N2 non-small cell lung cancer
  Cancer, 1994
• A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1994
• The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0)
  The Annals of Thoracic Surgery, 1988
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958